https://www.selleckchem.com/pr....oducts/brefeldin-a.h
The aim of the study was to investigate a new possible background of increased risk of cardiovascular events in two forms of endocrine hypertension in primary aldosteronism (PA) and pheochromocytoma/paraganglioma (PPGL) in comparison to essential hypertension (EHT). Prothrombotic properties of the fibrin clot structure, impaired fibrinolysis and enhanced thrombin generation have been reported to be associated with increased cardiovascular risk. Patients with PA and PPGL were evaluated at baseline and re-evaluated 3 months after caus
Aimer
Commentaire
Partagez
